Page 11 - EASL POSTGRADUATE COURSE

THURSDAY, APRIL 23, 2015

Carcinogenesis and NAFLD 8:30 - 10:10

Q&A (QUESTIONS)
8:30 Case presentation

Heinz Zoller, Austria

8:45 Carcinogenesis and the spectrum of hepatic tumors in NASH
Augusto Villanueva, The United States

9:05 Liver cancer in NAFLD: magnitude of the problem
Jean-François Dufour, Switzerland

Do inflammation networks trigger NASH and drive its
9:25 progression?

Herbert Tilg, Austria

9:45 Impact of lifestyle on NASH (inclusive on HCC)
Ingrid Hickman, Australia

10:05 Q&A (ANSWERS)

10:10 - 10:30 Coffee break

Progression of liver disease in NAFLD 10:30 - 12:10

10:30 Q&A (QUESTIONS)
Case presentation

Grace Doleman, The United Kingdom

10:45 Who are the NAFLD patients at risk of disease progression?
Chris Day, The United Kingdom

11:05 NAFLD diabetes and alcohol: is there a safe threshold?
Stefano Bellentani, The United Kingdom

11:25 The course of cirrhotic NASH: how different is it from other
cirrhoses?

Arun J. Sanyal, The United States

11:45 Liver transplantation for NASH
Didier Samuel, France

12:05 Q&A (ANSWERS)

12:10 End

The International Liver Congress™ 2015 • Vienna, Austria • April 22–23, 2015 11